• About us
• Contact

Advertisement

Organisation › Details

AdBio Partners (Group)

AdBio partners (previously Advent France Biotechnology) is an AMF-regulated (the French financial market authority) company that invests in a range of sectors within life sciences – specifically in therapeutics-oriented projects. Its unique strategy combines early-stage investments in promising enterprises and strong entrepreneurial support to strengthen the company’s growth. Created in 2016, AdBio partners has made 22 European investments in France, Belgium, Spain and Ireland – with two funds: AFB Seed Fund I and AFB FII. AdBio partners has developed strong relationships within the European innovation ecosystem; as a result, it has attracted international VC syndicates to its portfolio companies. The operational team includes investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise. *AFB Seed Fund I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing. *

 

	Start	2021-12-07 renamed
	Predecessor	Advent France Biotechnology SAS (AFB)
	Industry	venture capital
	Industry 2	BIOTECH
	Person	Coutet, Matthieu (Advent France Biotechnology 201704 Managing Partner before Inserm Transfert)
	Person 2	Huriez, Alain (Advent France Biotechnology 201704 Managing Partner before Advent Life Sciences + TcLand + Neovacs)
	Region	Paris
	Country	France
	Street	4 rue Thénard
	City	75005 Paris
	Tel	+33-1-5681-6300
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: DiogenX SAS. (5/10/23). "Press Release: DiogenX Raises €27.5M Series A Financing to Advance Its First-in-Class Regenerative Treatment for Type 1 Diabetes Towards Clinical Development". Marseille.
		Record changed: 2024-02-12

Advertisement

More documents for AdBio Partners (Group)

• [1] Astraveus SAS. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris....
• [2] Calida Therapeutics SAS. (4/6/23). "Press Release: French Biotech Calida Therapeutics Launches with Seed Funding, Leveraging US Academic Research in Thrombo-inflammatory Disorders". Paris....
• [3] AdBio Partners SAS. (2/23/23). "Press Release: AdBio Partners Appoints Geoffroy de Ribains as Managing Partner". Paris....
• [4] Thabor Therapeutics SAS. (5/17/22). "Press Release: Thabor Therapeutics Appoints Jérémie Mariau as CEO". Paris....
• [5] AdBio Partners SAS. (5/3/22). "Press Release: AdBio Partners Welcomes Inserm Transfert as Investor in Second Fund – AFB Fund II". Paris....
• [6] AdBio Partners SAS. (12/7/21). "Press Release: Advent France Biotechnology Becomes AdBio Partners". Paris....
• [7] Advent France Biotechnology SAS. (9/30/21). "Press Release: Advent France Biotechnology Launches Its Second Fund with a First Close at €86M ($102M)". Paris....
• [8] Aglaia Therapeutics. (9/27/21). "Press Release: New Startup Aglaia Therapeutics Raises €4M in Seed Funding to Overcome Resistance in Oncology Targeted Therapies". Villejuif....
• [9] Advent France Biotechnology SAS. (6/8/21). "Press Release: Advent France Biotechnology Appoints Sidonie Fabre as CFO". Paris....
• [10] Augustine Therapeutics. (3/18/21). "Press Release: Augustine Therapeutics Appoints Sylvain Celanire as CEO to Accelerate Development of Innovative Medicines for Rare Neuromuscular Diseases". Leuven....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.